AU2002309122A1 - Compositions based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes - Google Patents

Compositions based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes

Info

Publication number
AU2002309122A1
AU2002309122A1 AU2002309122A AU2002309122A AU2002309122A1 AU 2002309122 A1 AU2002309122 A1 AU 2002309122A1 AU 2002309122 A AU2002309122 A AU 2002309122A AU 2002309122 A AU2002309122 A AU 2002309122A AU 2002309122 A1 AU2002309122 A1 AU 2002309122A1
Authority
AU
Australia
Prior art keywords
diabetes
improving
amino acids
branched chain
chain amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002309122A
Other languages
English (en)
Inventor
Franco Conti
Francesco Saverio Dioguardi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Professional Dietetics SpA
Original Assignee
Professional Dietetics SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Professional Dietetics SpA filed Critical Professional Dietetics SpA
Publication of AU2002309122A1 publication Critical patent/AU2002309122A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002309122A 2001-06-15 2002-06-10 Compositions based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes Abandoned AU2002309122A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2001TO000580A ITTO20010580A1 (it) 2001-06-15 2001-06-15 Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete.
ITTO2001A000580 2001-06-15
PCT/IB2002/002149 WO2002102360A2 (en) 2001-06-15 2002-06-10 Compositions based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes

Publications (1)

Publication Number Publication Date
AU2002309122A1 true AU2002309122A1 (en) 2003-01-02

Family

ID=11458964

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002309122A Abandoned AU2002309122A1 (en) 2001-06-15 2002-06-10 Compositions based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes

Country Status (12)

Country Link
US (2) US20040157903A1 (enExample)
EP (1) EP1399139B1 (enExample)
JP (1) JP4364632B2 (enExample)
KR (1) KR100894365B1 (enExample)
AU (1) AU2002309122A1 (enExample)
CA (1) CA2448745C (enExample)
CY (1) CY1115918T1 (enExample)
DK (1) DK1399139T3 (enExample)
ES (1) ES2527527T3 (enExample)
IT (1) ITTO20010580A1 (enExample)
PT (1) PT1399139E (enExample)
WO (1) WO2002102360A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20030789A1 (it) 2003-10-07 2005-04-08 Professional Dietetics Srl Composizione a base di amino acidi per il trattamento
EP1537865A1 (de) * 2003-12-03 2005-06-08 Franz-Peter Dr. Liebel Verwendung von schwefelhaltigen Verbindungen und proteolytischen Enzymen zur Prophylaxe und Therapie des UDP-Glucuronosyl-transferase 1-defizitären Diabetes mellitus Typ II
EP1537864A1 (de) * 2003-12-03 2005-06-08 Franz-Peter Dr. Liebel Verwendung von Aminosäuren und schwefeltragenden Verbindungen zur Prophylaxe und Therapie des UDP-Glucuronosyltransferase1-defizitären Diabetes mellitus Typ II
US20080032915A1 (en) * 2004-02-12 2008-02-07 Campina Nederland Holding B.V. Cysteine Rich Peptides for Improving Thiol Homeostasis
JP2008056566A (ja) * 2004-12-28 2008-03-13 Toudai Tlo Ltd 低酸素応答促進剤
JP2009536016A (ja) * 2006-01-20 2009-10-08 インエル ビョルク， アミノ酸を含む食品組成物
US8633192B2 (en) 2006-12-15 2014-01-21 Tima Foundation Compositions and uses thereof
EP2117596B1 (en) * 2006-12-15 2018-01-03 TIMA Foundation Antioxidant composition and its use in diabetes
US8795973B2 (en) * 2010-11-29 2014-08-05 University of Leceister Methods for identifying inhibitors of mannan-binding lectin associated serine protease (MASP) proteins and uses thereof
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
IT201700087359A1 (it) * 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
MA49906A (fr) 2017-08-14 2020-06-24 Axcella Health Inc Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053589A (en) * 1975-11-24 1977-10-11 Control Drug Inc. Method of treating nutritional deficiency during cardiac cachexia, diabetes, hypoglycemia, gastroenterology, lipid, cell glycogen and keratin-related skin conditions and alcoholism
JPS60255722A (ja) 1984-05-30 1985-12-17 Otsuka Pharmaceut Factory Inc 糖尿病用アミノ酸輸液
US5032608A (en) * 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
AU655780B2 (en) * 1990-10-30 1995-01-12 Clintec Nutrition Company A method and composition for the protection of a metabolic recovery of ischemic cardiac tissue
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
LU88369A1 (fr) * 1993-07-12 1994-04-01 Michel Urso Prof Medecin Et Ch Acides aminés à chaînes ramifiées
IT1289754B1 (it) 1996-12-16 1998-10-16 Professional Dietetics Srl Composizioni a base di aminoacidi
IT1320783B1 (it) * 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al miglioramento delleprestazioni muscolari.
IT1320782B1 (it) * 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.

Also Published As

Publication number Publication date
CY1115918T1 (el) 2017-01-25
WO2002102360A2 (en) 2002-12-27
PT1399139E (pt) 2015-01-14
EP1399139B1 (en) 2014-10-15
US8653136B2 (en) 2014-02-18
WO2002102360A3 (en) 2003-05-30
CA2448745A1 (en) 2002-12-27
US20080194665A1 (en) 2008-08-14
KR100894365B1 (ko) 2009-04-22
ES2527527T3 (es) 2015-01-26
DK1399139T3 (en) 2015-01-12
KR20040008217A (ko) 2004-01-28
CA2448745C (en) 2012-09-04
JP4364632B2 (ja) 2009-11-18
EP1399139A2 (en) 2004-03-24
JP2004534073A (ja) 2004-11-11
ITTO20010580A1 (it) 2002-12-15
US20040157903A1 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
AU2002234645A1 (en) Amino dicarboxylic acid derivatives with pharmaceutical properties
AU2003225160A1 (en) "biosensor for dialysis therapy"
AU2278601A (en) Dual-mode processor
AU2003294056A1 (en) Polyamino acids functionalized by at least one (oligo)amino acid group and therapeutic uses
AU2000276362A1 (en) Composition for the treatment of diabetes
AU2002309122A1 (en) Compositions based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes
AU1433901A (en) Excitatory amino acid derivatives
AU4711400A (en) Lipocalin family protein
AU2002343025A1 (en) Improvements in footwear
AU2002224060A1 (en) Novel fructosyl amino acid oxidase
AU3473800A (en) Conotoxin peptides
AU2003232108A1 (en) 1,1- and 1,2-bisphosphonates as apoliprotein e modulators
AU2003276657A1 (en) Liposomal composition comprising haptotactic peptides
AU3452700A (en) Antibodies to placental protein 13
AU5034200A (en) Oxidoreductase proteins
AU2001268461A1 (en) Uncoupling proteins as targets for the treatment of heart failure
AU2002326756A1 (en) Ascorbic acid derivatives with amino acids
AU2001258543A1 (en) Branched amino acids
AU2002358879A1 (en) Polymer-structured composition containing lipophilic amino acid derivatives
AU2001284736A1 (en) Haplotypes of the pla2g1b gene
AU2003271085A1 (en) Amino acid iron complex
AU2002357370A1 (en) Treatment for averting or delaying premature delivery
AU4617100A (en) Supplementary drinks used in the diagnosis of diabetes
AU2002254057A1 (en) In vivo assay for anti angiogenic compounds
AU1316201A (en) Polypeptide composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase